Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue Citizens Financial Group CFG Q1 2026 Earnings EPS Beat by 281 Amid Steady Performance Penumbra Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed ANIP Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution Surrozen Q1 2026 Earnings Staggering EPS Miss of 1165 Versus Estimate Stock Declines 266